Answers are grounded in this paper and cite their sources.
The gene editing tool CRISPR-Cas has become the foundation for developing numerous molecular systems used in research and, increasingly, in medical practice. In particular, Cas proteins devoid of nucleolytic activity (dead Cas proteins; dCas) can be used to deliver functional cargo to programmed sites in the genome. In this review, we describe current CRISPR systems used for developing different dCas-based molecular approaches and summarize their most significant applications. We conclude with comments on the state-of-art in the CRISPR field and future directions.
No takes yet. Share an insight, caveat, or question.
Brezgin et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: